Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes
DPP-4抑制剂沙格列汀上市后安全性研究：一项涵盖五项结局指标的大规模多国队列研究
期刊:Bmj Open Diabetes Research & Care
影响因子:4.1
doi:10.1136/bmjdrc-2017-000400
Lo Re, Vincent; Carbonari, Dean M; Saine, M Elle; Newcomb, Craig W; Roy, Jason A; Liu, Qing; Wu, Qufei; Cardillo, Serena; Haynes, Kevin; Kimmel, Stephen E; Reese, Peter P; Margolis, David J; Apter, Andrea J; Reddy, K Rajender; Hennessy, Sean; Bhullar, Harshvinder; Gallagher, Arlene M; Esposito, Daina B; Strom, Brian L
